Expanded Use of Cannabidiol Oral Solution

Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy

NCT05803434 ·Status: UNKNOWN ·Phase: PHASE2

Study of Cannabidiol for Drug-Resistant Epilepsies

NCT03014440 ·Status: NO_LONGER_AVAILABLE

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

NCT02318537 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy

NCT02987114 ·Status: COMPLETED ·Phase: PHASE2

Cannabis Extract in Refractory Epilepsy Study

NCT03808935 ·Status: TERMINATED ·Phase: PHASE3

Cannabidiol in Children With Refractory Epileptic Encephalopathy

NCT03024827 ·Status: UNKNOWN ·Phase: PHASE1

Epidiolex and Drug Resistant Epilepsy in Children

NCT02397863 ·Status: AVAILABLE

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

NCT07233239 ·Status: RECRUITING ·Phase: PHASE1

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy

NCT02523183 ·Status: UNKNOWN

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

NCT02286986 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy

NCT02660255 ·Status: APPROVED_FOR_MARKETING

Epidiolex® for Anxiety in Pediatric Epilepsy

NCT05324449 ·Status: COMPLETED ·Phase: PHASE4

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

NCT02224573 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

NCT02224690 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy

NCT05678881 ·Status: TERMINATED ·Phase: PHASE1

A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy

NCT02783092 ·Status: UNKNOWN ·Phase: PHASE3

Role of the Gut Microbiota in Pediatric Epilepsy

NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

NCT00422422 ·Status: COMPLETED ·Phase: PHASE2

Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting

NCT03336450 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

NCT02091375 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy

NCT02914314 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy

NCT03222349 ·Status: COMPLETED ·Phase: PHASE2

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

NCT04903314 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

NCT05288283 ·Status: TERMINATED ·Phase: PHASE3